The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
Open accessAbstract
CD4 T-cell help is required during the generation and maintenance of effective antitumor CD8 T cell-mediated immunity. The goal of this study was to determine whether HER-2/neu-specific CD8 T-cell immunity could be elicited using HER-2/neu-derived MHC class II "helper" peptides, which contain encompassed HLA-A2-binding motifs. Nineteen HLA-A2 patients with HER-2/neu-overexpressing cancers received a vaccine preparation consisting of putative HER-2/neu helper peptides p369-384, p688-703, and p971-984. Contained within these sequences are the HLA-A2-binding motifs p369-377, p689-697, and p971-979. After vaccination, the mean peptide-specific T-cell precursor frequency to the HLA-A2 peptides increased in the majority of patients. In addition, the peptide-specific T cells were able to lyse tumors. The responses were long-lived and detectable for more than 1 year after the final vaccination in select patients. These results demonstrate that HER-2/neu MHC class II epitopes containing encompassed MHC class I epitopes are able to induce long-lasting HER-2-specific IFN-gamma-producing CD8 T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., Säve-Söderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., & Reed, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1049 · Cited by 838
Proceedings of the American Association for Cancer Research.
Konings, E. J. M., van den Brandt, P. A., Saris, W. H. M., Brants, H. A. M., & Goldbohm, R. A. (2001) · Cited by 764
Jäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.265 · Cited by 725
Panina‐Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G., & Lanzavecchia, A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191209 · Cited by 713
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Fisk, B., Blevins, T. L., Wharton, J. T., & Ioannides, C. G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2109 · Cited by 543
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Peoples, G. E., Goedegebuure, P. S., Smith, R., Linehan, D. C., Yoshino, I., & Eberlein, T. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.432 · Cited by 439
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Disis, M. L., Grabstein, K. H., Sleath, P. R., & Cheever, M. A. (1999) · PubMed · Cited by 340
Self-citationGreenberg, P. D., Cheever, M. A., & Fefer, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.952 · Cited by 312
Human tumor antigens for cancer vaccine development
Wang, R., & Rosenberg, S. A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01331.x · Cited by 296
Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2257 · Cited by 290
Kawashima, I., Hudson, S. J., Tsai, V., Southwood, S., Takesako, K., Appella, E., Sette, A., & Celis, E. (1998) · Human Immunology · doi:10.1016/s0198-8859(97)00255-3 · Cited by 229
Ressing, M. E., van Driel, W. J., Brandt, R. M. P., Kenter, G. G., de Jong, J. H., Bauknecht, T., Fleuren, G.-J., Hoogerhout, P., Offringa, R., Sette, A., et al. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200003000-00010 · Cited by 168
A sensitive ELISPOT assay to detect low-frequency human T lymphocytes
McCutcheon, M., Wehner, N., Wensky, A., Kushner, M., Doan, S., Hsiao, L., Calabresi, P., Ha, T., Tran, T. V., Tate, K. M., et al. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00182-8 · Cited by 158
In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help
Fayolle, C., Dériaud, E., & Leclerc, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4069 · Cited by 148
Disis, M. L., Smith, J. W., Murphy, A. E., Chen, W., & Cheever, M. A. (1994) · PubMed · Cited by 148
Self-citationWeber, J. S., Hua, F. L., Spears, L., Marty, V., Kuniyoshi, C., & Celis, E. (1999) · Journal of Immunotherapy · doi:10.1097/00002371-199909000-00007 · Cited by 125
Ioannides, C. G., Fisk, B. A., Fan, D., Biddison, W. E., Wharton, J. T., & O’Brian, C. A. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1233 · Cited by 118
Ha, P., Schwarz, S. L., Wunderlich, J. R., & Rosenberg, S. A. (1998) · PubMed · Cited by 110
Lewis, J. J., Janetzki, S., Schaed, S. G., Panageas, K. S., Wang, S., Williams, L. J., Meyers, M. L., Butterworth, L., Livingston, P. O., Chapman, P. B., et al. (2000) · International Journal of Cancer · Cited by 106
Asai, T., Storkus, W. J., & Whiteside, T. L. (2000) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.2.145-154.2000 · Cited by 99
Widmann, C., Romero, P. J., Maryanski, J. L., Corradin, G., & Valmori, D. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90275-x · Cited by 96
Therapy with cultured T cells: principles revisited
Cheever, M. A., & Chen, W. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00982.x · Cited by 89
Engstrand, M., Tournay, C., Peyrat, M. A., Eriksson, B., Wadström, J., Wirgart, B. Z., Romagn, F., Bonneville, M., tterman, T. H. T., & Korsgren, O. (2000) · Transplantation · doi:10.1097/00007890-200006150-00005 · Cited by 88
Immunity to the HER‐2/neu Oncogenic Protein
Disis, M. L., Bernhard, H., Gralow, J. R., Hand, S. L., Emery, S., Calenoff, E., & Cheever, M. A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514672.ch13 · Cited by 21
Self-citation
Cited by
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationImmunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Cancer vaccines: the next immunotherapy frontier
Lin, M. J., Svensson-Arvelund, J., Lubitz, G. S., Marabelle, A., Melero, I., Brown, B. D., & Brody, J. D. (2022) · Nature Cancer · doi:10.1038/s43018-022-00418-6 · Cited by 843
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
“DCs were loaded with three distinct HLA-A2–binding Her-2/neu peptides (31) at 5 μg/ml”
Method
Metadata
- Authors
- Knutson, K. L., Schiffman, K., & Disis, M. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-02-15
- Volume
- 107
- Issue
- 4
- Pages
- 477-484
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2148177811
- Cited by
- 439
- References
- 31
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.